Skip to main content
BDRX logo

BDRX · Biodexa Pharmaceuticals Plc

$1.54 +0.07 (+4.76%) At close · Aug 7
Market Cap
$1.39M
Shares
904,066

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

The Jun 30, 2026 filing window is still open — showing the latest known positions. Funds that have not filed yet carry their prior-quarter positions; a fund that filed without this stock counts as sold out. Each fund's Change is measured against its own previous reported quarter, shown in the Reported column. Pick a completed quarter in the Quarter selector below to put every fund on one quarter and see the stock-wide activity breakdown.
Holders: 8
Total Value: $219,588
Total Shares: 355,668

Institutional Ownership Trend

14 quarters

Holder Concentration

Across 8 13F filers
Top Holder
69.8%
Jun 2023 → Mar 2026 · range 28.9% – 97.3%
of institutional value
Top 5
100.0%
Jun 2023 → Mar 2026 · range 92.6% – 100.0%
of institutional value
Top 10
100.0%
Jun 2023 → Mar 2026 · range 100.0% – 100.0%
of institutional value
HHI
5,578
Jun 2023 → Mar 2026 · range 2,049 – 9,474
Highly concentrated
Showing 8 of 8
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1643918 CUSIP 59564R872 13F (30d) 3 filings 3 filers Visit website